drugset / Trial / NCT05771194

Analysis of Postoperative Ocular Surface Changes and Intervention Effect After PPV in MGD Dry Eye Patients

NCT05771194

Phase 4 Completed 40 enrolled Tianjin Medical University Eye Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

AIM: To observe ocular surface changes after phacovitrectomy in patients with mild to moderate meibomian gland dysfunction (MGD)-type dry eye and track clinical treatment response using a Keratograph 5M and a LipiView interferometer. METHODS: Forty cases were randomized into control group A and treatment group B; the latter received meibomian gland treatment 3 days before phacovitrectomy and sodium hyaluronate before and after surgery. The average non-invasive tear film break-up time (NITBUTav), first non-invasive tear film break-up time (NITBUTf), non-invasive measured tear meniscus height (NTMH), meibomian gland loss (MGL), lipid layer thickness (LLT) and partial blink rate (PBR) were measured preoperatively and 1 week, 1 month and 3 months postoperatively.

Timeline

Start
2021-02-01
Primary completion
2022-03-20
Completion
2022-07-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sodium Hyaluronate Other / unclassified 0.1 % Topical
Background Fluorometholone Other / unclassified 0.1 %
Background Gatifloxacin Small molecule Topical
Background Pranoprofen Small molecule
Background tropicamide Small molecule

Indications